【重大事项】：
中国通号(03969)近期在轨道交通市场共中标七个重要项目
和誉-B(02256)附属和誉医药完成创新PRMT5*MTA抑制剂ABSK131的 1期临床试验首例患者给药
宜搜科技(02550)联手超算科技成立Novus Infusion 主攻非物质文化遗产RWA平台
传承教育集团(08195)向联交所提交有关建议转板上市的正式申请
【财务数据】：
药明合联(02268)发盈喜 预期上半年净利润同比增长超过50%
归创通桥(02190)发盈喜 预期上半年公司股权拥有人应占溢利净额将超过1.15亿元 同比增长约66.9%
深圳控股(00604)上半年总合同销售额约68.14亿元，同比上升10.3%
中广核矿业(01164)：第二季度旗下投资的矿山共生产天然铀695.6tU 本季度计划完成率110.3%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.